相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Gene Therapy Leaves a Vicious Cycle
Reena Goswami et al.
FRONTIERS IN ONCOLOGY (2019)
Limitations and Off-Target Effects of Tryptophan-Related IDO Inhibitors in Cancer Treatment
Juliane Guenther et al.
FRONTIERS IN IMMUNOLOGY (2019)
Kynurenine 3-monooxygenase is a critical regulator of renal ischemia-reperfusion injury
Xiaozhong Zheng et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Immune control by amino acid catabolism during tumorigenesis and therapy
Henrique Lemos et al.
NATURE REVIEWS CANCER (2019)
Role of IDO and TDO in Cancers and Related Diseases and the Therapeutic Implications
Zixiang Ye et al.
JOURNAL OF CANCER (2019)
Trace derivatives of kynurenine potently activate the aryl hydrocarbon receptor (AHR)
Seung-Hyeon Seok et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Axicabtagene ciloleucel, a first-in-class CAR T cell therapy for aggressive NHL
Zachary J. Roberts et al.
LEUKEMIA & LYMPHOMA (2018)
Hypothesis kynurenic and quinolinic acids: The main players of the kynurenine pathway and opponents in inflammatory disease
Abdulla A-B. Badawy
MEDICAL HYPOTHESES (2018)
Mitochondria, Oxidative Stress and the Kynurenine System, with a Focus on Ageing and Neuroprotection
Katalin Sas et al.
MOLECULES (2018)
Genetic alterations affecting the genes encoding the enzymes of the kynurenine pathway and their association with human diseases
Fanni A. Boros et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2018)
Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health
Ludivine Laurans et al.
NATURE MEDICINE (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Indoleamine 2 3-dioxygenase knockout limits angiotensin II-induced aneurysm in low density lipoprotein receptor-deficient mice fed with high fat diet
Sarvenaz Metghalchi et al.
PLOS ONE (2018)
Kynurenic Acid: The Janus-Faced Role of an Immunomodulatory Tryptophan Metabolite and its Link to Pathological Conditions
Elisa Wirthgen et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Role of indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy
Lilla Hornyak et al.
FRONTIERS IN IMMUNOLOGY (2018)
Butyrate Produced by Commensal Bacteria Down-Regulates Indolamine 2,3-Dioxygenase 1 (IDO-1) Expression via a Dual Mechanism in Human Intestinal Epithelial Cells
Camille Martin-Gallausiaux et al.
FRONTIERS IN IMMUNOLOGY (2018)
Antisense oligonucleotides in neurological disorders
Claudia D. Wurster et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2018)
The Absence of Indoleamine 2,3-Dioxygenase Inhibits Retinal Capillary Degeneration in Diabetic Mice
Rooban B. Nahomi et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2018)
IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients
Weili Wang et al.
CANCER RESEARCH (2018)
Absence of kynurenine 3-monooxygenase reduces mortality of acute viral myocarditis in mice
Hisako Kubo et al.
IMMUNOLOGY LETTERS (2017)
Genetic variants of the kynurenine-3-monooxygenase and postpartum depressive symptoms after cesarean section in Chinese women
Sai-Ying Wang et al.
JOURNAL OF AFFECTIVE DISORDERS (2017)
Hypertryptophanemia due to tryptophan 2,3-dioxygenase deficiency
Patrick Ferreira et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Tryptophan availability for kynurenine pathway metabolism across the life span: Control mechanisms and focus on aging, exercise, diet and nutritional supplements
Abdulla A-B. Badawy
NEUROPHARMACOLOGY (2017)
Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis
Tobias V. Lanz et al.
SCIENTIFIC REPORTS (2017)
Tryptophan-Derived 3-Hydroxyanthranilic Acid Contributes to Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Mice In Vivo
Qiongxin Wang et al.
CIRCULATION (2017)
Aortic Aneurysms
Hong Lu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation
Henrique Lemos et al.
CANCER RESEARCH (2016)
Prognostic value of indoleamine 2,3-dioxygenase activity and expression in nasopharyngeal carcinoma
Ahlem Ben-Haj-Ayed et al.
IMMUNOLOGY LETTERS (2016)
Loss of Kynurenine 3-Mono-oxygenase Causes Proteinuria
Ron Korstanje et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Negative Impact of Hypoxia on Tryptophan 2,3-Dioxygenase Function
Frank Elbers et al.
MEDIATORS OF INFLAMMATION (2016)
CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands
Bruno Lamas et al.
NATURE MEDICINE (2016)
IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
David H. Munn et al.
TRENDS IN IMMUNOLOGY (2016)
Antioxidant Properties of Kynurenines: Density Functional Theory Calculations
Aleksandr V. Zhuravlev et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
Virus Infections Incite Pain Hypersensitivity by Inducing Indoleamine 2,3 Dioxygenase
Lei Huang et al.
PLOS PATHOGENS (2016)
Cytokines IL-17 and IL-22 in the host response to infection
Maria Valeri et al.
PATHOGENS AND DISEASE (2016)
IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis
Karen Put et al.
PLOS ONE (2016)
The Deficiency of Indoleamine 2,3-Dioxygenase Aggravates the CCl4-Induced Liver Fibrosis in Mice
Hideyuki Ogiso et al.
PLOS ONE (2016)
Genetic polymorphisms associated with the inflammatory response in bacterial meningitis7
Fabricia Lima Fontes et al.
BMC MEDICAL GENETICS (2015)
Atherosclerosis: a chronic inflammatory disease mediated by mast cells
Pio Conti et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations
Zsuzsanna Bohar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
pCMV-vegf165 Intramuscular Gene Transfer is an Effective Method of Treatment for Patients With Chronic Lower Limb Ischemia
Roman V. Deev et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2015)
Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms
Tamas Roszer
MEDIATORS OF INFLAMMATION (2015)
IL-27 induces the expression of IDO and PD-L1 in human cancer cells
Grazia Carbotti et al.
ONCOTARGET (2015)
Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics
Kenji Fukuno et al.
LEUKEMIA & LYMPHOMA (2015)
IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer Cells
Saman Maleki Vareki et al.
PLOS ONE (2015)
The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity
Jacques C. Mbongue et al.
VACCINES (2015)
Activation of NAD( P) H Oxidase by Tryptophan-Derived 3-Hydroxykynurenine Accelerates Endothelial Apoptosis and Dysfunction In Vivo
Qiongxin Wang et al.
CIRCULATION RESEARCH (2014)
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes
Maria Teresa Pallotta et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
Activation of the STING Adaptor Attenuates Experimental Autoimmune Encephalitis
Henrique Lemos et al.
JOURNAL OF IMMUNOLOGY (2014)
The kynurenine pathway is involved in bacterial meningitis
Leonam G. Coutinho et al.
JOURNAL OF NEUROINFLAMMATION (2014)
The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression
C. Lavebratt et al.
MOLECULAR PSYCHIATRY (2014)
Genome-wide association analyses identify variants in developmental genes associated with hypospadias
Frank Geller et al.
NATURE GENETICS (2014)
IDO1 and IDO2 Non-Synonymous Gene Variants: Correlation with Crohn's Disease Risk and Clinical Phenotype
Alexander Lee et al.
PLOS ONE (2014)
Association of kynurenine-3-monooxygenase gene with schizophrenia
V. E. Golimbet et al.
RUSSIAN JOURNAL OF GENETICS (2014)
Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophrenia
Ikwunga Wonodi et al.
SCHIZOPHRENIA RESEARCH (2014)
Aryl hydrocarbon receptor and kynurenine: recent advances in autoimmune disease research
Nam Trung Nguyen et al.
FRONTIERS IN IMMUNOLOGY (2014)
Kynurenine 3-monooxygenase mediates inhibition of Th17 differentiation via catabolism of endogenous aryl hydrocarbon receptor ligands
Geoffrey L. Stephens et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Indoleamine 2,3 dioxygenase gene polymorphisms correlate with CD8+Treg impairment in systemic sclerosis
Samuele Tardito et al.
HUMAN IMMUNOLOGY (2013)
Targeted Deletion of Kynurenine 3-Monooxygenase in Mice A NEW TOOL FOR STUDYING KYNURENINE PATHWAY METABOLISM IN PERIPHERY AND BRAIN
Flaviano Giorgini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Kynurenines in the CNS: recent advances and new questions
Laszlo Vecsei et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Regulation of IDO Activity by Oxygen Supply: Inhibitory Effects on Antimicrobial and Immunoregulatory Functions
Silvia K. Schmidt et al.
PLOS ONE (2013)
Indoleamine 2,3 dioxygenase and metabolic control of immune responses
David H. Munn et al.
TRENDS IN IMMUNOLOGY (2013)
Tumoral indoleamine 2,3-dioxygenase expression predicts poor outcome in laryngeal squamous cell carcinoma
Jin Ye et al.
VIRCHOWS ARCHIV (2013)
The role of indoleamine 2,3-dioxygenase in LP-BPM5 murine retroviral disease progression
Megan A. O'Connor et al.
VIROLOGY JOURNAL (2013)
A road less traveled paved by IDO silencing Harnessing the antitumor activity of neutrophils
Edwin R. Manuel et al.
ONCOIMMUNOLOGY (2013)
Indoleamine 2,3-Dioxygenase and Metabolites Protect Murine Lung Allografts and Impair the Calcium Mobilization of T Cells
Khadija Iken et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
Systemic Delivery of Salmonella typhimurium Transformed with IDO shRNA Enhances Intratumoral Vector Colonization and Suppresses Tumor Growth
Celine A. Blache et al.
CANCER RESEARCH (2012)
Quinolinic acid, the inescapable neurotoxin
Gilles J. Guillemin
FEBS JOURNAL (2012)
Serum analysis of tryptophan catabolism pathway: Correlation with Crohn's disease activity
Nitin K. Gupta et al.
INFLAMMATORY BOWEL DISEASES (2012)
Indoleamine-2,3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapy
Dongdong Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
L-Tryptophan-Kynurenine Pathway Metabolites Regulate Type I IFNs of Acute Viral Myocarditis in Mice
Masato Hoshi et al.
JOURNAL OF IMMUNOLOGY (2012)
Induction of Indoleamine 2,3-Dioxygenase by Uropathogenic Bacteria Attenuates Innate Responses to Epithelial Infection
Jennifer A. Loughman et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Flavivirus infection induces indoleamine 2,3-dioxygenase in human monocyte-derived macrophages via tumor necrosis factor and NF-κB
Amanda W. S. Yeung et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
The kynurenine system and immunoregulation
Yvette Mandi et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls
Maria Holtze et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2012)
Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder
Jessica A. Cutler et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Different Partners, Opposite Outcomes: A New Perspective of the Immunobiology of Indoleamine 2,3-Dioxygenase
Ciriana Orabona et al.
MOLECULAR MEDICINE (2012)
Association of a polymorphism in the indoleamine-2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C
A. K. Smith et al.
MOLECULAR PSYCHIATRY (2012)
M-tuberculosis Induces Potent Activation of IDO-1, but This Is Not Essential for the Immunological Control of Infection
Antje Blumenthal et al.
PLOS ONE (2012)
Making Sense of the Cytokine Storm: A Conceptual Framework for Understanding, Diagnosing, and Treating Hemophagocytic Syndromes
Scott W. Canna et al.
PEDIATRIC CLINICS OF NORTH AMERICA (2012)
Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenase
Buvana Ravishankar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
Luc Pilotte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The IL-17 pathway as a major therapeutic target in autoimmune diseases
Yan Hu et al.
YEAR IN IMMUNOLOGY (2011)
Downregulated Kynurenine 3-Monooxygenase Gene Expression and Enzyme Activity in Schizophrenia and Genetic Association With Schizophrenia Endophenotypes
Ikwunga Wonodi et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Association of kynurenine aminotransferase II gene C401T polymorphism with immune response in patients with meningitis
Fladjule Rejane Soares de Souza et al.
BMC MEDICAL GENETICS (2011)
Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C
Amanda Galvao-de Almeida et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
A Rare Variant at the KYNU Gene Is Associated With Kynureninase Activity and Essential Hypertension in the Han Chinese Population
Yi Zhang et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2011)
Involvement of Indoleamine 2,3-Dioxygenase in Impairing Tumor-Infiltrating CD8(+) T-Cell Functions in Esophageal Squamous Cell Carcinoma
Ge Zhang et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2011)
Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis
Daniela Fenoglio et al.
CLINICAL IMMUNOLOGY (2011)
Amelioration of Rat Collagen-Induced Arthritis Through CD4+ T Cells Apoptosis and Synovial Interleukin-17 Reduction by Indoleamine 2,3-Dioxygenase Gene Therapy
Shih-Yao Chen et al.
HUMAN GENE THERAPY (2011)
L-Kynurenine-induced apoptosis in human NK cells is mediated by reactive oxygen species
Hyunkeun Song et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies
Michael A. Nalls et al.
LANCET (2011)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A. Opitz et al.
NATURE (2011)
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells
Maria T. Pallotta et al.
NATURE IMMUNOLOGY (2011)
Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions
Elizabeth D. Mellins et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Kynurenine 3-monooxygenase (KMO) polymorphisms in schizophrenia: An association study
Maria Holtze et al.
SCHIZOPHRENIA RESEARCH (2011)
Structure, expression, and function of kynurenine aminotransferases in human and rodent brains
Qian Han et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells
Joshua D. Mezrich et al.
JOURNAL OF IMMUNOLOGY (2010)
The Absence of IDO Upregulates Type I IFN Production, Resulting in Suppression of Viral Replication in the Retrovirus-Infected Mouse
Masato Hoshi et al.
JOURNAL OF IMMUNOLOGY (2010)
IDO Upregulates Regulatory T Cells via Tryptophan Catabolite and Suppresses Encephalitogenic T Cell Responses in Experimental Autoimmune Encephalomyelitis
Yaping Yan et al.
JOURNAL OF IMMUNOLOGY (2010)
A potential role for indoleamine 2,3-dioxygenase (IDO) in Rhodococcus equi infection
M. C. Heller et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2010)
Indoleamine 2,3 Dioxygenase-Mediated Tryptophan Catabolism Regulates Accumulation of Th1/Th17 Cells in the Joint in Collagen-Induced Arthritis
Gabriel Criado et al.
ARTHRITIS AND RHEUMATISM (2009)
L-kynurenine treatment alters contextual fear conditioning and context discrimination but not cue-specific fear conditioning
Amy C. Chess et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Characterization and evolution of vertebrate indoleamine 2, 3-dioxygenases IDOs from monotremes and marsupials
Hajime J. Yuasa et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY (2009)
Antimicrobial and immunoregulatory properties of human tryptophan 2,3-dioxygenase
Silvia K. Schmidt et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Follow-up examination of linkage and association to chromosome 1q43 in multiple sclerosis
J. L. McCauley et al.
GENES AND IMMUNITY (2009)
Co-operative action of interleukin-10 and interferon-γ to regulate dendritic cell functions
Yoshiki Yanagawa et al.
IMMUNOLOGY (2009)
Indoleamine 2,3-Dioxygenase in Intestinal Immunity and Inflammation
Bobby J. Cherayil
INFLAMMATORY BOWEL DISEASES (2009)
Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells
Marc Veldhoen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Reduced Cytotoxic Function of Effector CD8+ T Cells Is Responsible for Indoleamine 2,3-Dioxygenase-Dependent Immune Suppression
Hanzhong Liu et al.
JOURNAL OF IMMUNOLOGY (2009)
Blockade of Indoleamine 2,3-Dioxygenase Protects Mice against Lipopolysaccharide-Induced Endotoxin Shock
In Duk Jung et al.
JOURNAL OF IMMUNOLOGY (2009)
Upregulation of indoleamine 2,3-dioxygenase in hepatocyte during acute hepatitis caused by hepatitis B virus-specific cytotoxic T lymphocytes in vivo
Naoki Iwamoto et al.
LIVER INTERNATIONAL (2009)
Biomarkers of AAA progression. Part 1: extracellular matrix degeneration
Femke A. M. V. I. Hellenthal et al.
NATURE REVIEWS CARDIOLOGY (2009)
Identification of genetic variants in the human indoleamine 2,3-dioxygenase (IDO1) gene, which have altered enzyme activity
Million Arefayene et al.
PHARMACOGENETICS AND GENOMICS (2009)
Infectious tolerance via the consumption of essential amino acids and mTOR signaling
Stephen P. Cobbold et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
TGF-β and kynurenines as the key to infectious tolerance
Maria L. Belladonna et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Localization of indoleamine 2,3-dioxygenase in human esophageal squamous cell carcinomas
Jinzhong Liu et al.
VIRCHOWS ARCHIV (2009)
Deficiency of indoleamine 2,3-dioxygenase enhances commensal-induced antibody responses and protects against Citrobacter rodentium-induced colitis
Lynne Harrington et al.
INFECTION AND IMMUNITY (2008)
The Janus-face kynurenic acid
Eva Rozsa et al.
JOURNAL OF NEURAL TRANSMISSION (2008)
Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro
John C. Tilton et al.
JOURNAL OF VIROLOGY (2008)
RAPping production of type I interferon in pDCs through mTOR
Mauro Costa-Mattioli et al.
NATURE IMMUNOLOGY (2008)
Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge:: A role for IFN-γ?
Thomas J. Connor et al.
NEUROSCIENCE LETTERS (2008)
Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation
Hui Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis
Ciriana Orabona et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Expression Pattern of Immune Suppressive Cytokines and Growth Factors in Oesophageal Adenocarcinoma Reveal a Tumour Immune Escape-promoting Microenvironment
F. Milano et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2008)
Indoleamine 2,3-dioxygenase gene transfer prolongs cardiac allograft survival
Jianping Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Global control of aberrant splice-site activation by auxiliary splicing sequences:: evidence for a gradient in exon and intron definition
Jana Kralovicova et al.
NUCLEIC ACIDS RESEARCH (2007)
Post-translational regulation of human indoleamine 2,3-dioxygenase activity by nitric oxide
Shane R. Thomas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan
Richard Metz et al.
CANCER RESEARCH (2007)
Metabolic endotoxemia initiates obesity and insulin resistance
Patrice D. Cani et al.
DIABETES (2007)
The liver: A special case in transplantation tolerance
Volker Benseler et al.
SEMINARS IN LIVER DISEASE (2007)
Elevations of endogenous kynurenic acid produce spatial working memory deficits
Amy C. Chess et al.
SCHIZOPHRENIA BULLETIN (2007)
Xanthurenic aciduria due to a mutation in KYNU encoding kynureninase
M. Christensen et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2007)
Kynurenine pathway in major depression:: Evidence of impaired neuroprotection
Aye-Mu Myint et al.
JOURNAL OF AFFECTIVE DISORDERS (2007)
Inflammatory abdominal aortic aneurysm
David B. Hellmann et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Sleeping Beauty-based gene therapy with indoleamine 2,3-dioxygenase inhibits lung allograft fibrosis
Hanzhong Liu et al.
FASEB JOURNAL (2006)
Reinstalling antitumor immunity by inhibiting tumor-derived immunosuppressive molecule IDO through RNA interference
Xiufen Zheng et al.
JOURNAL OF IMMUNOLOGY (2006)
Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35
Jinghong Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Severe sepsis exacerbates cell-mediated immunity in the lung due to an altered dendritic cell cytokine profile
Haitao Wen et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Association study between kynurenine 3-monooxygenase gene and schizophrenia in the Japanese population
N. Aoyama et al.
GENES BRAIN AND BEHAVIOR (2006)
Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression
SC Beutelspacher et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Novel action of indoleamine 2,3-dioxygenase attenuating acute lung allograft injury
HZ Liu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder
CL Miller et al.
BRAIN RESEARCH (2006)
Local expression of indoleamine 2,3-dioxygenase protects engraftment of xenogeneic skin substitute
Yunyuan Li et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Cutting edge:: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN type 1 signaling
AL Mellor et al.
JOURNAL OF IMMUNOLOGY (2005)
Role of kynurenines in the central and peripherial nervous systems
H Németh et al.
CURRENT NEUROVASCULAR RESEARCH (2005)
A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type IIFN signaling following B7 ligation
B Baban et al.
INTERNATIONAL IMMUNOLOGY (2005)
GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase
DH Munn et al.
IMMUNITY (2005)
Association of tryptophan 2,3 dioxygenase gene polymorphism with autism
R Nabi et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2004)
Endogenous kynurenic acid disrupts prepulse inhibition
S Erhardt et al.
BIOLOGICAL PSYCHIATRY (2004)
IDO expression by dendritic cells: Tolerance and tryptophan catabolism
AL Mellor et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Inflammation: the link between insulin resistance, obesity and diabetes
P Dandona et al.
TRENDS IN IMMUNOLOGY (2004)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling
XS Gao et al.
NATURE CELL BIOLOGY (2002)
Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase
G Frumento et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells:: Mediation of suppression by tryptophan metabolites
P Terness et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Indoleamine 2,3-dioxygenase expression in trans-planted NOD islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes
AM Alexander et al.
DIABETES (2002)
Antioxidants inhibit indoleamine 2,3-dioxygenase in IFN-γ-activated human macrophages:: Posttranslational regulation by pyrrolidine dithiocarbamate
SR Thomas et al.
JOURNAL OF IMMUNOLOGY (2001)
Th2 cytokines and asthma: an introduction
PJ Barnes
RESPIRATORY RESEARCH (2001)
Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.
AMJ Shapiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Induction of tryptophan 2,3-dioxygenase in the mouse endometrium during implantation
K Tatsumi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Natural interferon α/β-producing cells link innate and adaptive immunity
N Kadowaki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice
A Daugherty et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Analysis of transcription factors regulating induction of indoleamine 2,3-dioxygenase by IFN-γ
MX Du et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2000)
分享论文
